Hannah Every
@hannahoften
PGY-2 @DOMSinaiNYC | @SunyDownstate ‘23 | Aspiring cardiologist interested in prevention & heart failure 🫀 | Forever a NYT crossword addict
ID: 1315463455
30-03-2013 00:03:38
797 Tweet
217 Followers
321 Following
We could protect Roe tomorrow, but Sinema refuses to act on the filibuster. Until that changes she can take a seat talking about “women’s access to health care.” Hold everyone contributing to this disaster accountable, GOP & Dem obstructionists included. She should be primaried.
As ever Elizabeth Warren has the appropriate response to GOP power grabs
A few days late but thrilled to announce that I will be staying in New York City and completing my Internal Medicine Residency at Mount Sinai Department of Medicine!! Couldn’t be more excited for what’s to come. #Match2023 Mount Sinai Internal Medicine Chief Residents
In patients w/ cardiovascular disease & overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8 mos. Full SELECT trial results: nej.md/465pj91 #AHA23 AHA Science
Just wrapped our first ever Women in Cardiology panel Mount Sinai Fuster Heart Hospital! Incredible turnout and powerful conversations about representation, intersectionality, and the future of our field. Thank you to incredible panelists #AnnapoornaKini Anu Lala-Trindade Maya H. Barghash, MD Isha Ranadive, MD MPH for
So proud of these rockstar budding 🫀🩺 Icahn School of Medicine at Mount Sinai Mount Sinai Department of Medicine for their poster and sim pub Journal of Cardiac Failure #ACC2025 Prevention for #FunctionNotFailure is critical! onlinejcf.com/article/S1071-…
Most viewed this week from JAMA Cardiology: Patients with heart failure and HFimpEF remain at high risk for cardiovascular events, but finerenone consistently reduces this risk without significant adverse effects. ja.ma/4mA4snK